About: covid:05b0c934f1725c298940503d54c872da2e496895

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:05b0c934f1725c298940503d54c872da2e496895 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Dhanda, Sandeep Davies, Miranda Evans, Alison Lane, Samantha Osborne, Vicki Roy, Debabrata Saad Shakir, ·
is schema:about of	named entity 'compared' named entity 'remdesivir' named entity 'update' named entity 'worldwide' named entity 'shorter' named entity 'adverse events' named entity 'compared' named entity 'Google Scholar' named entity 'remdesivir' named entity 'disease' named entity 'Systematic' named entity 'CONSIDERED' named entity 'BENEFIT' named entity 'STANDARD OF CARE' named entity 'DATA' named entity 'REDUCED' named entity 'INFORMATION' named entity 'METHODS' named entity 'CURRENT' named entity 'LIMITED' named entity 'RISK OF' named entity 'key' named entity 'assessment' named entity 'key' named entity 'observed' named entity 'provide' named entity 'objective' named entity 'patients' named entity 'systematic' named entity 'profile' named entity 'COVID-19' named entity 'standard' named entity 'remdesivir' named entity 'remdesivir' named entity 'incorporated' named entity 'BRAT' named entity 'recovery' named entity 'placebo' named entity 'public health' named entity 'infection' named entity 'benefits and risks' named entity 'remdesivir' named entity 'standard of care' named entity 'remdesivir' named entity 'remdesivir' named entity 'placebo' named entity 'COVID-19' named entity 'risk assessment' named entity 'COVID' named entity 'Gilead' named entity 'placebo-controlled clinical trial' named entity 'US Food and Drug Administration' named entity 'data extraction' named entity 'mortality risk' named entity 'World Health Organisation' named entity 'COVID-19 pandemic' named entity 'non-invasive ventilation' named entity 'placebo group' named entity 'acute respiratory distress syndrome' named entity 'risk assessment' named entity 'control group' named entity 'remdesivir' named entity 'clinical trial' named entity 'causality' named entity 'remdesivir' named entity 'multiple organ dysfunction syndrome' named entity 'COVID' named entity 'NIAID' named entity 'phase III study' named entity 'wNCB' named entity 'statistically significant' named entity 'remdesivir' named entity 'coronavirus' named entity 'risk assessment' named entity 'SARS-CoV-2' named entity 'in-vivo' named entity 'COVID' named entity 'Primary endpoint' named entity 'statistically significant' named entity 'Multiple organ dysfunction' named entity 'placebo' named entity 'supplemental oxygen' named entity 'clinical trial' named entity 'SARS-CoV-2' named entity 'remdesivir' named entity 'COVID-19 disease' named entity 'placebo' named entity 'Fever' named entity 'Controlled Trial' named entity 'fewer deaths' named entity 'infection' named entity 'remdesivir' named entity 'pharmaceutical companies'

Attributes

Values

Creator

Dhanda, Sandeep
Davies, Miranda
Evans, Alison
Lane, Samantha
Osborne, Vicki
Roy, Debabrata
Saad Shakir, ·

is schema:about of

named entity 'compared'
named entity 'remdesivir'
named entity 'update'
named entity 'worldwide'
named entity 'shorter'
named entity 'adverse events'
named entity 'compared'
named entity 'Google Scholar'
named entity 'remdesivir'
named entity 'disease'
named entity 'Systematic'
named entity 'CONSIDERED'
named entity 'BENEFIT'
named entity 'STANDARD OF CARE'
named entity 'DATA'
named entity 'REDUCED'
named entity 'INFORMATION'
named entity 'METHODS'
named entity 'CURRENT'
named entity 'LIMITED'
named entity 'RISK OF'
named entity 'key'
named entity 'assessment'
named entity 'key'
named entity 'observed'
named entity 'provide'
named entity 'objective'
named entity 'patients'
named entity 'systematic'
named entity 'profile'
named entity 'COVID-19'
named entity 'standard'
named entity 'remdesivir'
named entity 'remdesivir'
named entity 'incorporated'
named entity 'BRAT'
named entity 'recovery'
named entity 'placebo'
named entity 'public health'
named entity 'infection'
named entity 'benefits and risks'
named entity 'remdesivir'
named entity 'standard of care'
named entity 'remdesivir'
named entity 'remdesivir'
named entity 'placebo'
named entity 'COVID-19'
named entity 'risk assessment'
named entity 'COVID'
named entity 'Gilead'
named entity 'placebo-controlled clinical trial'
named entity 'US Food and Drug Administration'
named entity 'data extraction'
named entity 'mortality risk'
named entity 'World Health Organisation'
named entity 'COVID-19 pandemic'
named entity 'non-invasive ventilation'
named entity 'placebo group'
named entity 'acute respiratory distress syndrome'
named entity 'risk assessment'
named entity 'control group'
named entity 'remdesivir'
named entity 'clinical trial'
named entity 'causality'
named entity 'remdesivir'
named entity 'multiple organ dysfunction syndrome'
named entity 'COVID'
named entity 'NIAID'
named entity 'phase III study'
named entity 'wNCB'
named entity 'statistically significant'
named entity 'remdesivir'
named entity 'coronavirus'
named entity 'risk assessment'
named entity 'SARS-CoV-2'
named entity 'in-vivo'
named entity 'COVID'
named entity 'Primary endpoint'
named entity 'statistically significant'
named entity 'Multiple organ dysfunction'
named entity 'placebo'
named entity 'supplemental oxygen'
named entity 'clinical trial'
named entity 'SARS-CoV-2'
named entity 'remdesivir'
named entity 'COVID-19 disease'
named entity 'placebo'
named entity 'Fever'
named entity 'Controlled Trial'
named entity 'fewer deaths'
named entity 'infection'
named entity 'remdesivir'
named entity 'pharmaceutical companies'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software